Fundraising Fox

Giles Brown

Executive VP Drug Discovery at Amphista

Little Abington, England, United Kingdom

Find your path to Giles

304 people in our graph share verified history with Giles — schools, employers, funds. One of them is your warm intro.

Chris BischoffunlockedGiles: together at University of Bristol (1993–1996)
×7Giles: together at University of Pennsylvania
Giles: together at Amphista
×3Giles: together at Henley Business School

Executive VP Drug Discovery at Amphista

Intro paths

→

In turn, Giles can intro founders to Amphista's investors below.

Amphista's investors · 8

Advent Life SciencesLondon · since 2020Dementia Discovery FundLondon · since 2022European Investment FundLuxembourgForbionNaardenGilde HealthcareUtrecht · $1.1M – $55M checksNovartis Venture FundBasel · $5M – $25M checksScottish Investment BankGlasgow · $250K – $2M checksSV Health InvestorsBoston · $1M – $20M checks

Experience

  1. Amphista Therapeutics LimitedEVP, Drug Discoverycurrent2026 — present
  2. Amphista Therapeutics LimitedSVP, Chemistry2023 — 2026
  3. Dunad TherapeuticsSVP, Medicinal Chemistry2022 — 2023
  4. OMass TherapeuticsVP, Head of Medicinal Chemistry2018 — 2022Greater Oxford Area
  5. Sosei HeptaresHead of Medicinal Chemistry2018
  6. Sosei HeptaresDirector of Medicinal Chemistry2015 — 2018
  7. Sosei HeptaresAssociate Director2012 — 2015Welwyn Garden City, United Kingdom
  8. Sosei HeptaresSenior Scientist2010 — 2012Welwyn Garden City, United Kingdom
  9. Sobi - Swedish Orphan Biovitrum AB (publ)Team Leader2005 — 2009Greater Cambridge Area
  10. Cambridge Biotechnology LtdSenior Scientist2003 — 2004Greater Cambridge Area
  11. EvotecSenior Scientist2002Greater Oxford Area

Skills & more

Start-ups Management1Leadership3Start-up VenturesDrug Discovery63Medicinal Chemistry43R&D7Organic Chemistry28Drug Design18Biotechnology8Organic Synthesis11Research Project ManagementOutsourcing2
+8 moreProject ManagementProtein ChemistryPharmaceutical IndustryChemistryClinical TrialsClinical DevelopmentScienceLife Sciences
  • Fellow of the Royal Society of Chemistry - Chartered Scientist and Chartered Chemist — Royal Society of Chemistry

From Giles's professional profile.

Frequently asked questions

Who is Giles Brown?
Executive VP Drug Discovery at Amphista
Where does Giles Brown work?
Giles Brown is Executive VP Drug Discovery at Amphista.
Where did Giles Brown go to school?
Giles Brown studied at Henley Business School (Master of Business Administration (MBA), General Business Management); University of Pennsylvania (Post-Doctoral Research Associate, Organic Chemistry); University of Bristol (PhD, Organic Chemistry).

Same school

Also attended Henley Business School95

John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalJames ChapmanEntrepreneur in Residence at Cambridge Innovation Capital

+ 89 more

Also attended University of Pennsylvania1,415

Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners

+ 1,409 more

Also attended University of Bristol360

Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-Founder & former CTO of BeameryAlicia TaylorInvestment Director at Pembroke VCT

+ 354 more

Also attended Westcliff High School for Boys2

Alex PostlethwaiteFinance Director at Sprints CapitalGeorge EarleAccounts Assistant at MML UK Advisor

Shared employers

Also worked at Amphista Therapeutics Limited4

Dominic SchmidtGeneral Partner at Advent Life SciencesBart DzikowskiManaging Director, Head of Transactions & Legal at Novartis Venture FundMarianne UtengManaging Director at Novartis Venture FundChristian JungPartner at Dementia Discovery

Also worked at OMass Therapeutics6

Scott BillerInvestor at GV (Google Ventures)Diana BernsteinDirector at Northpond VenturesClaire BrownPartner at Oxford Science EnterprisesMagdalena JonikasPartner at Jeito CapitalRos DeeganFounder at OmassNathalie FranchimontChief Medical Officer at Beeline Medicines

Also worked at Sosei Heptares7

Anja KoenigGlobal Head of NVF at Novartis Venture FundBart DzikowskiManaging Director, Head of Transactions & Legal at Novartis Venture FundFiona H. MarshallInvestor at Novartis Venture FundOliver WalkerManaging Partner at CGS Management AGAnja KönigGlobal Head at Novartis Venture FundKerrie L. BradyExecutive Officer at Centrexion Therapeutics

+ 1 more

Also worked at Sobi - Swedish Orphan Biovitrum AB (publ)7

Fredrik LehmannInvestor at IndustrifondenKavita BjörkdahlInvestor at Almi InvestAnnette ClancyPharma M&A Strategy at Jeito CapitalMatthew GantzPresident and Chief Executive Officer at Castle Creek BiosciencesDavid MeekChief Executive Officer at Bluebird BioPeter G TraberExecutive Officer, Director at Galectin Therapeutics

+ 1 more